|

WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)

RECRUITINGN/ASponsored by Mayo Clinic
Actively Recruiting
PhaseN/A
SponsorMayo Clinic
Started2025-07-18
Est. completion2029-06-29
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07058064

Summary

The purpose of this study is to find a cost effective cardiovascular (CV) surveillance of cancer survivors over long periods of time to prevent the risk of progression of heart failure (HF) and related morbidity and mortality. Mobile device-based artificial intelligence (AI)-electrocardiogram (ECG) can reliably detect cardiac dysfunction in lymphoma and sarcoma survivors and smart watch based surveillance for cardiotoxicity is feasible and reliable.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* ability to understand study procedures and being willing to comply with them for the entire study length
* diagnosis of lymphoma or sarcoma with new start or 1 year after completion of anthracycline therapy

Exclusion Criteria:

* LVEF \<50% at baseline, or prior confirmed history of heart failure, persistent atrial fibrillation, left bundle branch block, or paced rhythm
* Unwilling or unable to give written informed consent
* Participants who have opted out of the Minnesota Research Authorization

Conditions4

CancerHeart DiseaseLymphomaSarcoma

Locations1 site

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
Tera Peck507-538-7425Peck.Tera@mayo.edu

Browse More Trials

Cancer trialsHeart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.